Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Genetic Technologies Ltd (GTG.AX)

Genetic Technologies Ltd (GTG.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Genetic Technologies Ltd 60-66 Hanover Street Fitzroy Melbourne VIC 3065 AUS

https://www.gtglabs.com P: +61 384127000 F: +61 384127040

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.

Key Statistics

Overview:

Market Capitalization, $K 5,671
Shares Outstanding, K 145,417
% of Institutional Shareholders 0.01%

Financials:

Annual Sales, $ 7,665 K
Annual Net Income, $ -12,017 K
Last Quarter Sales, $ 3,331 K
Last Quarter Net Income, $ -2,502 K

Growth:

1-Year Return -80.50%
3-Year Return -94.43%
5-Year Return -93.50%
5-Year Revenue Growth 213.17%

Per-Share Information:

Next Earnings Date N/A
EPS Growth vs. Prev Qtr -18.22%
EPS Growth vs. Prev Year 18.68%
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 12/14/23

GTG.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -184.98%
Return-on-Assets % -114.22%
Profit Margin % -156.78%
Debt/Equity 0.01
Price/Sales N/A
Price/Book 3.10
Book Value/Share 0.01
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar